GIM
DXCM icon

Glenmede Investment Management’s DexCom DXCM Stock Holding History

Glenmede Investment Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$503K Buy
7,469
+124
+2% +$9.81K ﹤0.01% 929
2025
Q2 		$641K Buy
+7,345
New +$576K ﹤0.01% 837

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Glenmede Investment Management's DXCM Position: Q3 2025 in Review

Glenmede Investment Management increased its DexCom (DXCM) stake by 1.7% in Q3 2025, buying an estimated $9.81K and bringing the position to 7,469 shares worth $503K. The position accounts for ﹤0.01% of the portfolio, ranked #929.

Glenmede Investment Management first reported a position in DXCM in Q2 2025 and has held it in 2 quarters since. The position peaked at $641K in Q2 2025. 910 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Glenmede Investment Management held 7,469 shares of DexCom worth $503K as of Q3 2025.
  • Glenmede Investment Management bought 124 DexCom shares in Q3 2025, an estimated $9.81K.
  • DexCom made up ﹤0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #929 holding.
  • Glenmede Investment Management first reported a position in DexCom in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's DexCom position peaked at $641K in Q2 2025.
  • 910 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.